CD5- 소포림프종의 CD5+ 광범위큰B세포림프종으로 전환된 = Transformation of CD5-Negative Follicular Lymphoma into CD5-Positive Diffuse Large B-Cell Lymphoma A Case Report

다국어 초록 (Multilingual Abstract)

Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of aggressive lymphomas. Approximately 10% of DLBCL cases express CD5 as a surface antigen. CD5-positive DLBCL can occur as the de novo or secondary type, De novo CD5-positive DLBCL arises without previous lymphoproliferative disease, and secondary CD5-positive DLBCL may or may not manifest as Richter syndrome. The transformation of follicular lymphoma (FL) into DLBCL occurs in approximately one-third of all cases. The transformation of CD5-negative low-grade B-cell lymphoma to CD5-positive DLBCL is extremely rare. We report the clinical features of a rare case that presented with a transformation from CD5-negative FL to CD5-positive DLBL over 11 years. This is the second such case published in the English literature.

참고문헌 (Reference)

1 김진만, "WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study" 대한병리학회 45 (45): 254-260, 2011

2 Yuna Lee, "Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy" 대한내과학회 21 (21): 183-186, 2006

3 Lossos IS, "Transformation of follicular lymphoma" 24 : 147-163, 2011

4 Bernstein SH, "The incidence, natural history, biology, and treatment of transformed lymphomas" 532-541, 2009

5 Maeshima AM, "Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome)" 131 : 339-346, 2009

6 Williams CD, "High-dose therapy and autologus stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin’s lymphoma: a-case matched study from the European Bone Marrow Transformed follicular lymphoma" 65 : 17-22, 2000

7 Yamaguchi M, "De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome" 105 : 1133-1139, 1999

8 Burastero SE, "Characterization of human CD5(Leu-1, OKT1)+ B lymphocytes and the antibodies theyproduce" 11 : 231-262, 1989

9 Sekiguchi Y, "CD5-positive follicular lymphoma: a case report and literature review" 50 : 899-904, 2011

10 Pospisil R, "CD5 is apotential selecting ligand for B-cell surface immunoglobulin: a possible role in maintenance and selective expansion of normal and malignant B cells" 36 : 353-365, 2000